The Role of PCSK9 Inhibitors in Reducing CV Risk: Patient Selection Criteria and Treatment Initiation Tactics
In this module of a Four-Part Expert Interview Series, Dr. Robert P. Giugliano, along with Dr Christopher P. Cannon, course chair, will examine the role of PCSK9 inhibitors in reducing CV risk. Dr. Guigliano will review optimal patient selection criteria and how it can be applied in daily practice. This module will allow learners to understand the relationship between LDL-C ...
View Course
View Course
Further Insights in Lowering LDL Cholesterol: Managing Atherosclerotic Disease in High-Risk Patients
In this module of a Four-Part Expert Interview Series, Dr. Marc P. Bonaca, along with Dr. Christopher P. Cannon, course chair, will discuss options for lowering LDL cholesterol in dyslipidemia patients. This will include recent outcomes from clinical trials and the diagnostic criteria of peripheral artery disease. Enabling physicians to recognize physical indicators of PAD will maximize treatment efforts in ...
View Course
View Course
Scientific Advances to Improve Outcomes in Patients with Idiopathic Pulmonary Fibrosis
This CME/CNE activity will review recent advances in Patients with Idiopathic Pulmonary Fibrosis (IPF) as presented at the American Thoracic Society (ATS) 2018 Conference in San Diego, California. The three expert faculty will analyze evidence based data on the current science and emerging therapeutics for the treatment of IPF. The faculty will also discuss how to collaborate with the interprofessional ...
View Course
View Course
An Update of Emerging Concepts in the Management of Alzheimer’s Disease
This CME/CNE program will highlight content presented at the Alzheimer’s Association International Conference (AAIC) 2018 held in Chicago, Illinois. The three expert faculty, led by Dr. Richard S. Isaacson, will provide an interactive account of recently released data regarding the treatment and management of patients with Alzheimer’s disease (AD). An overview of Alzheimer’s disease, including disease course, and signs and ...
View Course
View Course
Scientific Updates in the Reversal of Direct Oral Anticoagulants for Patients with an Acute Major Bleed
This continuing education activity will review optimal treatment strategies and recent clinical trial data for patients who require emergent reversal of their direct oral anticoagulant therapy as presented at the American College of Cardiology 2018 in Orlando, Florida. Three expert faculty will analyze clinical profiles of reversal agents and current strategies to treat direct oral anticoagulant associated bleeds in emergent ...
View Course
View Course
Applying Novel Nebulized LAMA Bronchodilators to Improve Outcomes in Patients With COPD
This CME/CNE activity will review recent advances in the treatment and management of chronic obstructive pulmonary disease (COPD) as presented at the American Thoracic Society (ATS) 2018 Conference in San Diego, California. Three expert faculty will review the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines, highlighting the significant changes over the last two years and their implications in clinical ...
View Course
View Course
Advancements in the Prevention and Management of Stroke
This CME/CNE webcast will highlight recent advancements in the prevention and management of stroke. The expert faculty will discuss best practices for assessing risk as well as the modifiable risk factors of stroke. Recent clinical trial data, including that of combination therapy, will be analyzed, as well as strategies for managing the comorbidities that commonly accompany stroke. Best practices for ...
View Course
View Course
Advanced Clinical Update of Emerging Therapeutics for the Treatment of Multiple Sclerosis
This CME program is derived from content presented at the 2017 Florida Society of Neurology Annual Meeting. Dr. Augusto Miravalle will review the pathophysiology of multiple sclerosis and how to make more effective treatment plans. Dr. Miravalle will analyze current and emerging clinical trial data for therapeutics in the treatment of multiple sclerosis. Finally, he will discuss how to implement ...
View Course
View Course
The Increasing Role of Biosimilars in Oncology
This continuing education activity will focus on recent clinical trial data as well as therapeutic advances in the increasing role of biosimilars in oncology. The three expert faculty will review the fundamentals of biosimilars in oncology, including bioequivalence, totality of evidence, and interchangeability. A review of current clinical trial data of biosimilars for the treatment of various oncologic therapeutic areas ...
View Course
View Course
The Role of Novel Therapeutics for the Treatment of Metastatic Colorectal Cancer
This continuing education activity will focus on recent clinical trial data and scientific advances in the treatment and management of patients with metastatic colorectal cancer as presented at the 2018 Gastrointestinal Cancers Symposium held in San Francisco, California. Three expert faculty will review the science of colorectal cancer, including patient screening guidelines and molecular characterization. Recent clinical trial data of ...
View Course
View Course